Enfamil Testing Results

December 27, 2011 by staff 

Enfamil Testing ResultsEnfamil Testing Results, Pediatric nutrition specialist Mead Johnson Nutrition Co. (MJN) on Tuesday saw its shares jumping higher in premarket trading, following a report of no bacteria found in its Enfamil baby formula.

A release Sunday morning noted that after “a new round of rigorous testing,” the formula has been declared safe for consumption. Last week, MJN shares were trounced following a scare that its Enfamil PREMIUM Newborn powdered formula could have been tainted with the Cronobacter (Enterobacter sakazakii) bacteria.

Major retailers like Wal-Mart (WMT), Safeway (SWY), and Walgreen (WAG) all voluntarily pulled the formula from store shelves amid the scare.

Mead Johnson shares rose $3.34, or +5.1%, in premarket trading Tuesday.

Shares of Mead Johnson Nutrition (MJN) have a 1.59% dividend yield, based on Friday’s closing stock price of $65.29. The stock has technical support in the $61-$65 price area. If the stock can firm up, we see overhead resistance around the all-time highs of $76-$77 a share.

Mead Johnson Nutrition Co. (MJN) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Report to Team

Please feel free to send if you have any questions regarding this post , you can contact on

Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.


Comments are closed.